American ginseng (Panax quinquefolius) is a herbaceous perennial plant in the ivy family, commonly used as Chinese or herbal medicine. An extract is sold as Cold-fX. It is native to eastern North America, though it is also cultivated in places such as China.
There is little evidence to support that American ginseng is effective in the common cold. All trials evaluating the efficacy were funded by the manufacturer and there has been poor data reporting. Health Canada's Natural Health Product Directorate states that it claims to "help reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system".
The plant's forked root and leaves were traditionally used for medicinal purposes by Native Americans. Since the 18th century, the roots have been collected by "sang hunters" and sold to Chinese or Hong Kong traders, who often pay very high prices for particularly old wild roots. It is also known by its Chinese name huaqishen (simplified Chinese: 花旗参; traditional Chinese: 花旗參; pinyin: huāqíshēn; Jyutping: faa1kei4sam1; literally: "Flower Flag ginseng") or xiyangshen (simplified Chinese: 西洋参; traditional Chinese: 西洋參; pinyin: xīyángshēn; Jyutping: sai1joeng4sam1; literally: "west ocean ginseng").
There is no evidence that American ginseng is effective in those infected with the common cold. The effect of preventative use is not clear. When used preventatively it makes no difference on the rate of infections. It also appears to have no effect on how bad the infections are. There is tentative evidence that it may lessen the length of sickness when used preventatively.
Individuals requiring anti-coagulant therapy such as warfarin should avoid use of American ginseng. Not recommended for individuals with impaired liver or renal function. It is not recommended in those who are pregnant or breastfeeding. Other adverse effects include: headaches, anxiety, trouble sleeping and an upset stomach.
American ginseng was formerly particularly widespread in the Appalachian and Ozark regions (and adjacent forested regions such as Pennsylvania, New York and Ontario), but due to its popularity and unique habitat requirements, the wild plant has been overharvested, as well as lost through destruction of its habitat, and is thus rare in most parts of the United States and Canada. Ginseng is also negatively affected by deer browsing, urbanization, and habitat fragmentation. It can also be grown commercially, under artificial shade, woods cultivated, or wild-simulated methods and is usually harvested after three to four years depending on cultivation technique; the wild-simulated method often requires up to 10 years before harvest.
Like Panax ginseng, American ginseng contains dammarane-type ginsenosides, or saponins, as the major biologically active constituents. Dammarane-type ginsenosides include two classifications: 20(S)-protopanaxadiol (PPD) and 20(S)-protopanaxatriol (PPT). American ginseng contains high levels of Rb1, Rd (PPD classification), and Re (PPT classification) ginsenosides—higher than that of P. ginseng in one study.
When taken orally, PPD-type ginsenosides are mostly metabolized by intestinal bacteria (anaerobes) to PPD monoglucoside, 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol (M1). In humans, M1 is detected in plasma from seven hours after intake of PPD-type ginsenosides and in urine from 12 hours after intake. These findings indicate M1 is the final metabolite of PPD-type ginsenosides.
Society and culture
Cold-fX is a product derived from the roots of North American ginseng (Panax quinquefolius). Originally manufactured by Afexa Life Sciences Inc. (formerly called CV Technologies Inc.), headquartered in Edmonton, Alberta, Canada, the company and lead product was acquired by Valeant Pharmaceuticals International (headquartered in Laval, Quebec, Canada) in 2011.
The makers of Cold-fX, were criticized for making health claims about the product that have never been tested or verified scientifically. Up until February 2007, the company advised a regimen of 18 pills over a course of 3 days in order to obtain "immediate relief" from a cold. Health Canada's review of the scientific literature confirmed that this is not a claim that CV Technologies Inc. is entitled to make.
- Panax_quinquefolius L., from "American medical botany being a collection of the native medicinal plants of the United States, containing their botanical history and chemical analysis, and properties and uses in medicine, diet and the arts" by Jacob Bigelow,1786/7-1879. Publication in Boston by Cummings and Hilliard,1817-1820.
- "Panax quinquefolius". NatureServe Explorer. NatureServe. Retrieved 2007-07-03.
- Xiang, Q.; Lowry, P. P. (2007). "Araliaceae". In Wu, Z. Y.; Raven, P. H.; Hong, D. Y. Flora of China (pdf) 13. St. Louis, MO: Missouri Botanical Garden Press. p. 491. ISBN 9781930723597.
- "Panax quinquefolius". eFloras.
- Nahas, R; Balla, A (Jan 2011). "Complementary and alternative medicine for prevention and treatment of the common cold.". Canadian family physician Medecin de famille canadien 57 (1): 31–6. PMC 3024156. PMID 21322286.
There are no trials evaluating ginseng for treatment of the common cold.
- Seida, JK; Durec, T; Kuhle, S (2011). "North American (Panax quinquefolius) and Asian Ginseng (Panax ginseng) Preparations for Prevention of the Common Cold in Healthy Adults: A Systematic Review.". Evidence-based complementary and alternative medicine : eCAM 2011: 282151. doi:10.1093/ecam/nep068. PMC 3136130. PMID 19592479.
- There is More to a Forest than Trees. research.vt.edu (Summer 2002)
- Beattie-Moss, M. (2006-06-19). "Roots and Regulations - The unfolding story of Pennsylvania ginseng". Pennstate news.
- McGraw, J. "Population Biology and Conservation Ecology of American Ginseng". West Virginia University.
- "Ginseng Prices at Highest in Decades". The Post Crescent. October 19, 2010.
- Zhu, S.; Zou, K.; Fushimi, H.; Cai, S.; Komatsu, K. (2004). "Comparative study on triterpene saponins of ginseng drugs". Planta Medica 70 (7): 666–677. doi:10.1055/s-2004-827192. PMID 15303259.
- Hasegawa, H.; Sung, J.-H.; Matsumiya, S.; Uchiyama, M. (1996). "Main ginseng saponin metabolites formed by intestinal bacteria". Planta Medica 62 (5): 453–457. doi:10.1055/s-2006-957938. PMID 8923812.
- Tawab, M. A.; Bahr, U.; Karas, M.; Wurglics, M.; Schubert-Zsilavecz, M. (2003). "Degradation of ginsenosides in humans after oral administration". Drug Metabolism and Disposition 31 (8): 1065–1071. doi:10.1124/dmd.31.8.1065. PMID 12867496.
- Oh, S.-H.; Lee, B.-H. (2004). "A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage". Toxicology and Applied Pharmacology 194 (3): 221–229. doi:10.1016/j.taap.2003.09.011. PMID 14761678.
- "What is COLD-fX intended for?". Cold-fX: Frequently Asked Questions. Retrieved 2007-11-24.
- Charlie Gillis (2007-03-26). "COLD-fX catches the sniffles again". Macleans Magazine.
|Wikispecies has information related to: Panax quinquefolius|
|Wikimedia Commons has media related to Panax quinquefolius.|
- "There is More to a Forest than Trees" by Lynn Davis, College of Natural Resources, Virginia Tech
- "Roots and Regulations: The Unfolding Story of Pennsylvania Ginseng", by Melissa Beattie-Moss